Skip to content

Clinical trials

Completed Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Status: Completed Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20024
20034
20045
20054
20065
20076
200810
200913
20104
20115
20129
20136
20144
20152
20163
20176
201810
20194
20202
20212
20226
20235
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed133

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
HaEmek Medical Center, Israel9
Carelon Research7
UCSF Benioff Children's Hospital Oakland6
Hangzhou Zede Pharma-Tech Co., Ltd.4
National Heart, Lung, and Blood Institute (NHLBI)4
Novo Nordisk A/S4
University of California, San Francisco4
Mahidol University3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia133
Anemia, Sickle Cell45
Iron Overload30
beta-Thalassemia21
Hemoglobinopathies18
Anemia, Diamond-Blackfan13
Anemia11
Hemochromatosis8
Hematologic Diseases6
Hypertension, Pulmonary6

Trials

Showing 76 to 100 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.